Water Island Capital’s Aratana Therapeutics, Inc. PETX Stock Holding History

Water Island Capital’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,421,559	Closed	-$7.33M	–	112
2019 Q2	$7.33M	Buy	+1,421,559	New	+$6.39M	0.34%	46

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Water Island Capital's PETX Position: Q3 2019 in Review

Water Island Capital sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 1,421,559 shares — an estimated $7.33M sold.

Water Island Capital first reported a position in PETX in Q2 2019 and held it in 1 quarter. The position peaked at $7.33M in Q2 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Water Island Capital reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Water Island Capital sold 1,421,559 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $7.33M.
Water Island Capital first reported a position in Aratana Therapeutics, Inc. in Q2 2019 and held it in 1 quarter.
Water Island Capital's Aratana Therapeutics, Inc. position peaked at $7.33M in Q2 2019.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Water Island Capital's 13F filing for Q3 2019, filed 12 Nov 2019.